Copyright
©The Author(s) 2025.
World J Gastrointest Endosc. Feb 16, 2025; 17(2): 100793
Published online Feb 16, 2025. doi: 10.4253/wjge.v17.i2.100793
Published online Feb 16, 2025. doi: 10.4253/wjge.v17.i2.100793
Figure 2 Comparison of each parameter among the endoscopic healing (n = 61), ileal (n = 43), colonic (n = 16), and ileocolonic groups (n = 13).
aP < 0.05; bP < 0.01; cP < 0.001. The endoscopic healing group exhibited significantly different leucine-rich alpha-2 glycoprotein, C-reactive protein, albumin, and Harvey-Bradshaw index compared with the ileal, colonic, and ileocolonic groups. A: Leucine-rich alpha-2 glycoprotein; B: C-reactive protein; C: Albumin; D: Harvey-Bradshaw index. LRG: Leucine-rich alpha-2 glycoprotein; EH: Endoscopic healing; CRP: C-reactive protein; HBI: Harvey-Bradshaw index.
- Citation: Ohno M, Nishida A, Otsuki A, Yokota Y, Imai T, Bamba S, Inatomi O. Leucine-rich alpha-2 glycoprotein as a superior biomarker to C-reactive protein for detecting small bowel lesions in Crohn’s disease. World J Gastrointest Endosc 2025; 17(2): 100793
- URL: https://www.wjgnet.com/1948-5190/full/v17/i2/100793.htm
- DOI: https://dx.doi.org/10.4253/wjge.v17.i2.100793